» Articles » PMID: 34590334

Effect of Intravenous Ghrelin Administration, Combined with Alcohol, on Circulating Metabolome in Heavy Drinking Individuals with Alcohol Use Disorder

Overview
Specialty Psychiatry
Date 2021 Sep 30
PMID 34590334
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ghrelin may influence several alcohol-related behaviors in animals and humans by modulating central and/or peripheral biological pathways. The aim of this exploratory analysis was to investigate associations between ghrelin administration and the human circulating metabolome during alcohol exposure in nontreatment seeking, heavy drinking individuals with alcohol use disorder (AUD).

Methods: We used serum samples from a randomized, crossover, double-blind, placebo-controlled human laboratory study with intravenous (IV) ghrelin or placebo infusion in two experiments. During each session, participants received a loading dose (3 µg/kg) followed by continuous infusion (16.9 ng/kg/min) of acyl ghrelin or placebo. The first experiment included an IV alcohol self-administration (IV-ASA) session and the second experiment included an IV alcohol clamp (IV-AC) session, both with the counterbalanced infusion of ghrelin or placebo. Serum metabolite profiles were analyzed from repeated blood samples collected during each session.

Results: In both experiments, ghrelin infusion was associated with an altered serum metabolite profile, including significantly increased levels of cortisol (IV-ASA q-value = 0.0003 and IV-AC q < 0.0001), corticosterone (IV-ASA q = 0.0202 and IV-AC q < 0.0001), and glycochenodeoxycholic acid (IV-ASA q = 0.0375 and IV-AC q = 0.0013). In the IV-ASA experiment, ghrelin infusion increased levels of cortisone (q = 0.0352) and fatty acids 18:1 (q = 0.0406) and 18:3 (q = 0.0320). Moreover, in the IV-AC experiment, ghrelin infusion significantly increased levels of glycocholic acid (q < 0.0001) and phenylalanine (q = 0.0458).

Conclusion: IV ghrelin infusion, combined with IV alcohol administration, was associated with increases in the circulating metabolite levels of corticosteroids and glycine-conjugated bile acids, among other changes. Further research is needed to understand the role that metabolomic changes play in the complex interaction between ghrelin and alcohol.

Citing Articles

A randomized, double-blind, placebo-controlled study of a GHSR blocker in people with alcohol use disorder.

Faulkner M, Farokhnia M, Lee M, Farinelli L, Browning B, Abshire K JCI Insight. 2024; 9(24).

PMID: 39704175 PMC: 11665556. DOI: 10.1172/jci.insight.182331.


Ketogenic Diet Initially Masks Symptoms of Hypercortisolism in Cushing's Disease.

Dugandzic M, Pierre-Michel E, Kalayjian T Metabolites. 2022; 12(11).

PMID: 36355116 PMC: 9693419. DOI: 10.3390/metabo12111033.

References
1.
Vestergaard E, Gormsen L, Jessen N, Lund S, Hansen T, Moller N . Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes. 2008; 57(12):3205-10. PMC: 2584125. DOI: 10.2337/db08-0025. View

2.
Sumner L, Amberg A, Barrett D, Beale M, Beger R, Daykin C . Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics. 2013; 3(3):211-221. PMC: 3772505. DOI: 10.1007/s11306-007-0082-2. View

3.
Zhang A, Price J, Leonard D, North C, Suris A, Javors M . Alcohol Use Disorder Masks the Effects of Childhood Adversity, Lifetime Trauma, and Chronic Stress on Hypothalamic-Pituitary-Adrenal Axis Reactivity. Alcohol Clin Exp Res. 2020; 44(6):1192-1203. DOI: 10.1111/acer.14334. View

4.
Clugston R, Jiang H, Lee M, Piantedosi R, Yuen J, Ramakrishnan R . Altered hepatic lipid metabolism in C57BL/6 mice fed alcohol: a targeted lipidomic and gene expression study. J Lipid Res. 2011; 52(11):2021-31. PMC: 3196234. DOI: 10.1194/jlr.M017368. View

5.
Farokhnia M, Faulkner M, Piacentino D, Lee M, Leggio L . Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder. Physiol Behav. 2019; 204:49-57. DOI: 10.1016/j.physbeh.2019.02.008. View